Subject: MJNA Subsidiary's Products Available in Brazil

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJNA Subsidiary's Products Available in Brazil
Hot Stock to WatchHot Stock to Watch

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

End of Day:

Price: 0.0488

Change (%): + 0.0003 (0.62)

Volume: 3,223,952
MJNA Chart

Medical Marijuana Inc.’s New Real Scientific Hemp Oil™ Liquid Product Line Now Available for Import Into Brazilian Market

New RSHO™ Product Line Includes All-Natural Non-GMO Hemp Oil with MCT Oil

SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) - Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce the immediate release of its new line of Real Scientific Hemp Oil™ (RSHO™) products with medium-chain triglyceride (MCT) oil for import into Brazil, through its exclusive distributor HempMeds Brasil™. This new liquid product line is an all-natural, non-GMO hemp oil formulation with MCT oil.

“Convenience is key,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “After listening to our customers who are using RSHO™ hemp CBD oil, we discovered that many were blending RSHO™ with coconut and/or MCT oil to optimize the consistency when providing it to their children. With the new RSHO™ liquid formulation of MCT oil and convenient dosing spoon, we are simplifying administering the product. We are extremely excited and pleased with this new product line and feel that the popularity of RSHO™ will further expand, as a result of making it more convenient for consumers to use.”

Continue Reading

Top PerformerYesterday's Top Performer

Smart Card Marketing Systems Inc. (Pink Sheets: SMKG)

End of Day:

Price: 0.015

Change (%): + 0.004 (36.36)

Volume: 20,000
SMKG Chart

About Smart Card Marketing Systems Inc. (Pink Sheets: SMKG)

SmartCard Marketing Systems Inc. develops EMV Payment, Check21, Mwallet & Incentive solutions for Issuer & Acquirer Banks, Telecom & Global Enterprise with Retail and Ecommerce Merchant portfolio. SmartCard enables their channel by bringing their merchants the best available technology enabled Multi-OS devices and E-commerce in a licensing & transaction based SAAS model.

Listen to 10/15/15 Audio Interview

Other Small Cap News

Company: Envoy Group Corp (Pink Sheets: ENVV)

Envoy Seeks Acquisitions

VALENCIA, CALIFORNIA--(Marketwired - Nov. 23, 2015) - Envoy Group Corp (OTC:ENVV) effective immediately Envoy Group Corp announces a restructuring of its business plan to reprioritize and become an acquirer within the consumer products market. Under the new plan new opportunities, products and companies will be brought into the Envoy Group umbrella for exciting strategic acquisitions and joint ventures.

To this end Envoy has recently entered into negotiations with two exciting premium brand retail product opportunities, Tryst Electronic Smoking Products and the other in the energy drink space, further details to follow.

Incorporating the highest quality, Tryst is already the market leader in Electronic Cigars with their Rubusto and Panatella E-Cigars. Tryst products are now carried by 17 major distributors.

Continue Reading

Market News

By Peter Schacknow: CNBC

Early movers: AGN, PFE, MNK, TSN, MTCH, FB, WMT & more

Check out which companies are making headlines before the bell:

Allergan, Pfizer - The two drug companies will combine in a deal valued at about 160 billion dollars. Allergan shareholders will receive 11.3 shares in the newly combined company for each share they now hold, valuing Allergan at $363.63 per share.

Mallinckrodt - The drug maker earned an adjusted $1.84 per share for its latest quarter, 8 cents above estimates, with revenue also well above forecasts. The company, whose stock was recently battered by a report from short seller Citron Research, was helped by a significant increase in its specialty drugs segment.

Tyson Foods - The food producer missed estimates by 5 cents with adjusted quarterly profit of 83 cents per share, though revenue was above forecasts. Tyson said it was upbeat about its performance, given less than optimum market conditions and the integration process following its acquisition of Hillshire Brands.

Continue Reading

By Stephanie Yang:

Sell stocks - they’re tremendously vulnerable: Investor

The S&P 500 closed out its best week of the year Friday, rising 3.27 percent. However, one investor is still very wary of the remarkable gains.

Chad Morganlander, portfolio manager at Stifel Nicolaus' Washington Crossing Advisors, recently went underweight the S&P, given the slowdown in corporate earnings and revenue.

"We believe that earnings growth is going to be lackluster in 2016 ... that's on the back of lackluster revenue growth," Morganlander said Friday on CNBC's "Power Lunch."

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks